Novozymes A/S NSIS-B.CO
Nasdaq Copenhagen · Basic Materials · Specialty Chemicals
460.00 DKK
−4.2%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Novozymes
| EUR million | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | – | 2,356 | 2,402 | 3,834 | 4,158 |
| EBITDA | – | 821 | 734 | 1,038 | 1,386 |
| Net income | – | 493 | 406 | 306 | 584 |
| Balance sheet | |||||
| Equity | – | 1,857 | 1,876 | 11,176 | 10,855 |
| Total debt | 832 | 919 | 1,039 | 1,797 | – |
| Cash | – | 140 | 150 | 280 | 275 |
| Net debt | – | 779 | 889 | 1,517 | – |
| Ratios and per share | |||||
| EBITDA margin | – | 34.8% | 30.6% | 27.1% | 33.3% |
| Profit margin | – | 20.9% | 16.9% | 8.0% | 14.0% |
| Return on equity | – | 26.6% | 21.6% | 2.7% | 5.4% |
| Earnings/share (EUR) | – | 1.78 | 1.46 | 0.66 | 1.25 |
| Book value/share (EUR) | – | 6.71 | 6.76 | 23.98 | 23.30 |
| Shares outstanding (M) | – | 277 | 277 | 466 | 466 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 49.1 |
| P/B | 2.6 |
| EV / EBITDA | 20.5 |
| Net debt / EBITDA | −0.2 |
| Return on equity | 5.4% |
| Profit margin | 14.0% |
| Beta 1Y | 0.31 |
| Revenue growth 1Y | +8.5% |
| Revenue CAGR 3Y | +20.8% |
| Earnings/share CAGR 3Y | −11.1% |
| ROE avg. 3Y | 9.9% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (DKK)
| 2026 | 6.60 |
| 2025 | 6.45 |
| 2024 | 4.00 |
| 2023 | 10.20 |
| 2022 | 5.50 |
Not investment advice. Figures may contain errors from the data source.